CSIMarket
 


Akebia Therapeutics Inc   (AKBA)
Other Ticker:  
 
 

Akebia Therapeutics Inc Accounts Receivables Turnover Ratio from the forth quarter 2023 to the forth quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Akebia Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the forth quarter 2023 to a ratio of 7.84, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the forth quarter 2023. Average collection period, for Akebia Therapeutics Inc 's accounts receivable remained unchanged at 47 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 71 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 832, from overall ranking in the third quarter 2023 at 1673.

What is Receivable Turnover Ratio?
What is Akebia Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




AKBA Receivables Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Receivable Change -2.47 % -2.17 % -76.09 % -72.47 % -20.82 %
Y / Y Revenue Change 1.84 % -14.13 % -55.53 % -34.96 % -7.62 %
Receivable Turnover Ratio (TTM) 7.84 7.73 7.96 6.65 5.58
AKBA's Total Ranking # 832 # 1673 # 2878 # 1955 # 1572
Average receivable collection period 47 47 46 55 65
Seq. Receivable Change 73.91 % 15.43 % 10.07 % -55.86 % 74.43 %
Seq. Revenue Change 33.36 % -25.42 % 40.49 % -27.12 % 12.45 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 15
Healthcare Sector # 72
Overall Market # 832

Receivable Turnover Ratio Statistics
High Average Low
0.77 0.47 0
(Dec 31 2023)   (Sep. 30, 2015)






Financial Statements
Akebia Therapeutics Inc 's Accounts Receivable $ 39 Millions Visit AKBA's Balance sheet
Akebia Therapeutics Inc 's Sales TTM $ 195 Millions Visit AKBA's Income Statement
Where are AKBA's Sales coming from? Visit AKBA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AKBA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for AKBA's Competitors
Receivables Turnover Ratio for AKBA's Suppliers
Accounts Receivables Turnover Ratio for AKBA's Customers

You may also want to know
AKBA's Growth Rates AKBA's Roa AKBA's Inventory Turnover Ratio AKBA's Dividend Comparisons
AKBA's Profitability Ratios AKBA's Roi AKBA's Asset Turnover Ratio AKBA's Dividend Growth
AKBA's Valuation Ratios AKBA's Roe AKBA's Financial Strength Ratios AKBA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Protalix Biotherapeutics inc   13.39 $ 65.494  Millions$ 4.890  Millions
Exact Sciences Corporation  13.25 $ 2,532.479  Millions$ 191.179  Millions
Utah Medical Products Inc  12.39 $ 50.658  Millions$ 4.088  Millions
Teladoc Health Inc   12.18 $ 2,602.415  Millions$ 213.613  Millions
Caribou Biosciences Inc   12.12 $ 34.477  Millions$ 2.844  Millions
Siga Technologies Inc  11.78 $ 139.917  Millions$ 11.881  Millions
Integrated Biopharma Inc  11.42 $ 48.833  Millions$ 4.275  Millions
Option Care Health Inc   11.09 $ 4,302.223  Millions$ 388.081  Millions
National Research Corporation  11.05 $ 148.580  Millions$ 13.445  Millions
National Healthcare Corp  10.98 $ 1,141.544  Millions$ 104.011  Millions
Revance Therapeutics Inc   10.95 $ 234.040  Millions$ 21.377  Millions
Biontech Se  10.68 $ 4,277.280  Millions$ 400.624  Millions
Arrowhead Pharmaceuticals Inc   10.29 $ 181.740  Millions$ 17.670  Millions
Viemed Healthcare Inc   10.22 $ 183.008  Millions$ 17.905  Millions
Sophia Genetics Sa  10.15 $ 61.913  Millions$ 6.100  Millions
Lumos Pharma Inc   10.07 $ 2.051  Millions$ 0.204  Millions
Semler Scientific Inc   9.93 $ 68.184  Millions$ 6.867  Millions
United Therapeutics Corporation  9.85 $ 2,327.500  Millions$ 236.175  Millions
Xoma Corporation  9.74 $ 4.758  Millions$ 0.489  Millions
Eton Pharmaceuticals Inc   9.66 $ 31.061  Millions$ 3.216  Millions
Procyon Corporation  9.64 $ 4.700  Millions$ 0.488  Millions
Innovative Eyewear Inc   9.62 $ 1.152  Millions$ 0.120  Millions
The Pennant Group Inc   9.54 $ 544.891  Millions$ 57.095  Millions
Voyager Therapeutics Inc   9.51 $ 250.008  Millions$ 26.288  Millions
Irhythm Technologies Inc   9.27 $ 491.806  Millions$ 53.054  Millions
Lipella Pharmaceuticals Inc   9.11 $ 0.450  Millions$ 0.049  Millions
Harmony Biosciences Holdings inc   9.03 $ 581.786  Millions$ 64.448  Millions
Catalyst Pharmaceuticals Inc   8.96 $ 398.204  Millions$ 44.440  Millions
Fresenius Medical Care Ag  8.93 $ 21,788.051  Millions$ 2,440.676  Millions
Insmed Inc  8.84 $ 305.528  Millions$ 34.560  Millions

Date modified: 2024-03-15T05:44:41+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com